BROLUCIZUMAB-DBLL for Retinal neovascularisation: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 7 adverse event reports in the FDA FAERS database where BROLUCIZUMAB-DBLL was used for Retinal neovascularisation.

Most Reported Side Effects for BROLUCIZUMAB-DBLL

Side Effect	Reports	%	Deaths	Hosp.
Vitreous floaters	479	17.1%	4	18
Visual impairment	446	15.9%	1	28
Vision blurred	416	14.9%	2	15
Eye inflammation	387	13.8%	2	10
Visual acuity reduced	365	13.0%	1	19
Retinal vasculitis	323	11.5%	3	22
Uveitis	305	10.9%	1	16
Vitritis	284	10.1%	2	19
Eye pain	234	8.4%	0	18
Vitreous opacities	205	7.3%	1	15
Anterior chamber cell	199	7.1%	2	15
Blindness	191	6.8%	3	20
Keratic precipitates	183	6.5%	1	8
Death	178	6.4%	177	2
Drug ineffective	170	6.1%	0	5